Skip to content
SearchContact UsDirectionsHome
Whitehead Institute for Biomedical Research
About WhiteheadFaculty and ResearchResearch NewsPublic ProgramsCareer OpportunitiesSupport Whitehead
Research News
Search News Archives

On Topic

Multimedia News Summaries

Paradigm Magazine

Fact Sheets

Video Gallery

Podcast

For the News Media

whitehead home > research news > search news archives > 2006 news stories > lindquist and jaenisch elected to institute of medicine

Lindquist and Jaenisch elected to Institute of Medicine

CAMBRIDGE, Mass. (Oct. 12, 2006) — Whitehead Members Susan Lindquist and Rudolf Jaenisch were among 65 scientists elected to the Institute of Medicine (IOM) of the National Academies this week, bringing the total IOM membership to 1,651.

Both Lindquist and Jaenisch are also professors of biology at MIT, where Elazer R. Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences, was also elected. Lindquist and Jaenisch join Whitehead colleagues Gerald Fink, Eric Lander and Robert Weinberg as members of the IOM.

“It is a great pleasure to welcome these distinguished and influential individuals to the Institute of Medicine,” said IOM President Harvey V. Fineberg in a statement issued by the Institute. “Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care and public health. Election is considered one of the highest honors in the fields of medicine and health.”

The Institute of Medicine is unique for its structure as both an honorific membership organization and an advisory organization. Established in 1970 by the National Academy of Sciences, the institute has become recognized as a national resource for independent, scientifically informed analysis and recommendations on issues related to human health. With their election, members make a commitment to devote a significant amount of volunteer time as members of IOM study committees.

Studies from the institute completed in the past year include “The Future of Drug Safety: Promoting and Protecting the Health of the Public,” an agenda for addressing the vulnerabilities that have hindered the optimal functioning of the nation's drug safety system; “Preventing Medication Errors,” which documents the impact of drug-related mishaps and provides an agenda for improving the safety of medication use; and “The Future of Emergency Care,” a series of three reports that recommend steps to shore up the nation's struggling emergency care system.

Written by David Cameron.

Whitehead Institute for Biomedical Research is a nonprofit, independent research and educational institution. Wholly independent in its governance, finances and research programs, Whitehead shares a close affiliation with Massachusetts Institute of Technology through its faculty, who hold joint MIT appointments.

Lindquist
photo of Peter Reddien Whitehead Member Susan Lindquist

Photo: Justin Knight

photo of Peter Reddien Whitehead Member Rudolf Jaenisch

Photo: Sam Ogden


CONTACT

Communications and Public Affairs
Phone: 617-258-5183
Email: newsroom@wi.mit.edu

Whitehead Institute contact information